News Focus
News Focus
icon url

sulaco

05/14/13 1:21 PM

#122201 RE: biopharm #122200

Exactly, Bio. PPHM's Avid is a huge plus


I don't get the whiners here who dump on SK and the BOD. Yeah, they've had plenty of shortcomings, but what about the upsides?

IP owned 100%? Check.

Global rights in place? Check.

Manufacturing of lead oncology drug Bavi in-friggin-house? (Are you friggin' kidding me??) Check.

Yes, it's EXTREMELY rare that a small-cap biotech firm manufactures its own drug outright. Think of the savings. In-house. They know their lead drug so well they make it.

GLTAL